XML 85 R74.htm IDEA: XBRL DOCUMENT v3.20.2
Derivative Instruments, Hedging Activities and Fair Value - Derivatives Designated as Hedging Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Derivative [Line Items]        
Product Revenues $ 509,398 $ 423,155 $ 1,355,520 $ 1,103,955
Interest Expense (15,794) (12,819) (43,396) (24,429)
Gain or (loss) reclassified from AOCI into income (1,225)   (1,199)  
Interest rate swaps | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Interest Expense (739) 76 (1,849) 648
Income (loss) from discontinued business 0 0 0 (2,741)
Cross-currency interest rate swaps | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Interest Expense (312) (291) (912) (908)
Foreign currency exchange forward contracts | Amount Reclassified from Accumulated Other Comprehensive Loss | Effective Portion of Deriviatives Designated as Hedging Instruments        
Derivative [Line Items]        
Cost of services sold 0 0 0 44
Product Revenues | Interest rate swaps        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income 0      
Gain or (loss) reclassified from AOCI into income   0    
Product Revenues | Foreign exchange contracts        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income (174)   1,562  
Gain or (loss) reclassified from AOCI into income   (512)   977
Amount excluded from effectiveness testing recognized in earnings 12   208  
Amount excluded from effectiveness testing recognized in earnings   86   403
Derivative Instruments, Loss Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing 3   24  
Product Revenues | Cross-currency interest rate swaps        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income 0      
Gain or (loss) reclassified from AOCI into income   0    
Interest Expense | Interest rate swaps        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income (739)   (1,849)  
Gain or (loss) reclassified from AOCI into income   (76)   (648)
Interest Expense | Foreign exchange contracts        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income 0      
Gain or (loss) reclassified from AOCI into income   0    
Amount excluded from effectiveness testing recognized in earnings 0      
Amount excluded from effectiveness testing recognized in earnings   0    
Interest Expense | Cross-currency interest rate swaps        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income (312)   (912)  
Gain or (loss) reclassified from AOCI into income 312 291   908
Cost of services and products sold | Foreign currency exchange forward contracts        
Derivative [Line Items]        
Gain or (loss) reclassified from AOCI into income (174)   1,562  
Amount of Gain Recognized in Income on Derivatives (12,279) 10,642 (5,001) 15,735
Product Revenues        
Derivative [Line Items]        
Product Revenues 125,119 106,488 334,324 319,765
Cost of services sold 99,043 71,970 257,512 220,634
Products And Services, Service Revenue        
Derivative [Line Items]        
Product Revenues 384,279 316,667 1,021,196 784,190
Cost of services sold $ 313,136 239,519 $ 835,277 608,230
Gain or (loss) reclassified from AOCI into income   $ 0   $ (44)